Abstract
Introduction and hypothesis
Platelet-rich fibrin (PRF) matrix is an autologous leukocyte and PRF biomaterial. PRF is a fibrin matrix polymerized in a tetramolecular structure with the incorporation of platelets, leukocytes, cytokines, and circulating stem cells. The three-dimensional structure of PRF is optimal for migration of endothelial cells and fibroblasts. It permits rapid angiogenesis and easier remodeling of fibrin in a more resistant connective matrix. In vaginal surgery, PRF may act as a graft material with better healing and better functional outcome.
Methods
We performed a prospective observational study on ten consecutive women requiring surgery for prolapse recurrence (stage II or higher). These women had high risks for recurrence, erosion with graft materials, and intraoperative and postoperative complications with traditional pelvic reconstructive surgical procedures. ICS score and P-QoL Questionnaire results were assessed preoperatively and postoperatively. Surgery consisted of anterior, posterior, or apical repair plus PRF. Follow-up was performed at 1, 6, 12, 18, and 24 months.
Results
Anatomically, the success rate was 80%. Prolapse symptoms improved by 100%. Sexual activity increased by 20% without dyspareunia. The surgical time was satisfactory (mean, 38.5 min). There were no intraoperative or postoperative complications.
Conclusions
The use of PRF for site-specific prolapse repair is associated with a good functional outcome because of the healing and mechanical properties of PRF.
Similar content being viewed by others
References
Bako A, Dhar R (2009) Review of synthetic mesh-related complications in pelvic floor reconstructive surgery. Int Urogynecol J Pelvic Floor Dysfunct 20(1):103–11
Oslen AL, Smith VJ, Bergstrom JO et al (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506
Baessler K, Maher CF (2006) Mesh augmentation during pelvic floor reconstruction surgery: risks and benefits. Curr Opin Obstet Gynaecol 18(5):560–566
Collinet P, Belot F, Debodinance P et al (2006) Transvaginal mesh technique for pelvic organ prolapse repair: mesh exposure management and risk factors. Int Urogynecol J Pelvic Floor Dysfunct 17:315–320
Abed H, Rahn DD, Lowenstein L, Balk EM, Clemons JL, Rogers RG (2011) For the Systematic Review Group of the Society of Gynecologic Surgeons. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J Pelvic Floor Dysfunct. doi:10.1007/s00192-011-1384-5
Ridgeway B, Chen CC, Paraiso MF (2008) The use of synthetic mesh in pelvic reconstructive surgery. Clin Obstet Gynaecol 51(1):136–152
Liles W, Van Voorhis WC (1995) Nomenclature and biological significance of cytokines involved in inflammation and host immune response. J Infect Dis 172:1573–1582
Falconer C, Soderberg M, Blomgren B, Ulmsten U (2001) Influence of different sling materials on connective tissue metabolism in stress urinary incontinent women. Int Urogynecol J Pelvic Floor Dysfunct 12(Suppl 2):S19–S23
Spotnitz WD (2010) Fibrin sealant: past, present, and future: a brief review. World J Surg 34:632–634
Silver FH, Wang MC, Pins GD (1995) Review preparation and use of fibrin glue in surgery. Biomaterials 16(12):891–903
Van Hinsbergh VW et al (2001) Role of fibrin matrix in angiogenesis. Ann N Y Acad Sci 936:426–437
Anitua E, Sanchez M, Orive G, Andia I (2007) The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28:4551–60
Bhanot S, Alex JC (2002) Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18:27–33
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part III: leucocyte activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e51–5
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e37–44
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:e56–60
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL et al (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus lift. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:299–303
Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, Gogly B (2006) Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101(3):e45–50
Belcher E, Dusmet M, Jordan S, Ladas G, Lim E, Goldstraw P (2010) A prospective, randomized trial comparing BioGlue and Vivostat® for the control of alveolar air leak. J Thorac Cardiovasc Surg 140(1):32–38
Kjaergard HK, Trumbull HR (1998) Vivostat® system autologous fibrin sealant: preliminary study in elective coronary bypass grafting. Ann Thorac Surg 66:482–486
Digesu GA, Sand S, Kullar V et al (2003) Validation of an Italian version of prolapse quality of life questionnaire. Eur J Obstet Gynecol Reprod Biol 106:184–192
Nedelec B, Shankowsky HA, Tredget EE (2000) Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil 21(3):205–12
Salvatore S, Siesto G, Serati M (2010) Risk factors for recurrence of genital prolapse. Curr Opin Obstet Gynecol 22(5):420–424
Rinne KM, Kirkinen PP (1999) What predisposes young women to genital prolapse? Eur J Obstet Gynecol Reprod Biol 84:23–25
Van Dam JH, Hop WCJ, Schouten WR (2000) Analysis of patients with poor outcome of rectocele repair. Dis Colon Rectum 43:1556–1560
Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ (1996) Changes in metabolism of collagen in genitourinary prolapse. Lancet 347:1658–1661
Cervigini M, Natale F (2001) The use of synthetics in the treatment of pelvic organ prolapse. Curr Opin Urol 11(4):429–435
Rardin CR, Washington BB (2009) New considerations in the use of vaginal mesh for prolapse repair. J Minim Invasive Gynecol 16(3):360–364
Porter WE, Steele A, Walsh P, Kohli N, Karram MM (1999) The anatomic and functional outcomes of defect specific rectocele repairs. Am J Obstet Gynecol 181:1353–1359
Haylen BT, De Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 21(1):5–26
Acknowledgments
Special thanks to Mrs. Daniela Vaccaro for the statistical analysis and English review.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gorlero, F., Glorio, M., Lorenzi, P. et al. New approach in vaginal prolapse repair: mini-invasive surgery associated with application of platelet-rich fibrin. Int Urogynecol J 23, 715–722 (2012). https://doi.org/10.1007/s00192-012-1667-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-012-1667-5